Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta, GA 30912, USA.
Biochem Biophys Res Commun. 2010 Mar 26;394(1):75-80. doi: 10.1016/j.bbrc.2010.02.109. Epub 2010 Feb 21.
SMCT1 is a Na(+)-coupled monocarboxylate transporter expressed in a variety of tissues including kidney, thyroid, small intestine, colon, brain, and retina. We found recently that several non-steroidal anti-inflammatory drugs (NSAIDs) inhibit the activity of SMCT1. Here we evaluated the effect of diclofenac, also a NSAID, on SMCT1. SMCT1 cDNA was expressed heterologously in the human retinal pigment epithelial cell lines HRPE and ARPE-19, the human mammary epithelial cell line MCF7, and in Xenopus laevis oocytes. Transport was monitored by substrate uptake and substrate-induced currents. Na(+)-dependent uptake/current was considered as SMCT1 activity. The effect of diclofenac was evaluated for specificity, dose-response, and influence on transport kinetics. To study the specificity of the diclofenac effect, we evaluated the influence of this NSAID on the activity of several other cloned transporters in mammalian cells under identical conditions. In contrast to several NSAIDs that inhibited SMCT1, diclofenac stimulated SMCT1 when expressed in HRPE and ARPE-19 cells. The stimulation was marked, ranging from 2- to 5-fold depending on the concentration of diclofenac. The stimulation was associated with an increase in the maximal velocity of the transport system as well as with an increase in substrate affinity. The observed effect on SMCT1 was selective because the activity of several other cloned transporters, when expressed in HRPE cells and studied under identical conditions, was not affected by diclofenac. Interestingly, the stimulatory effect on SMCT1 observed in HRPE and ARPE-19 cells was not evident in MCF7 cells nor in the X. laevis expression system, indicating that SMCT1 was not the direct target for diclofenac. The RPE-specific effect suggests that the target of diclofenac that mediates the stimulatory effect is expressed in RPE cells but not in MCF7 cells or in X. laevis oocytes. Since SMCT1 is a concentrative transporter for metabolically important compounds such as pyruvate, lactate, beta-hydroxybutyrate, and nicotinate, the stimulation of its activity by diclofenac in RPE cells has biological and clinical significance.
SMCT1 是一种 Na(+)-偶联的单羧酸转运体,在多种组织中表达,包括肾脏、甲状腺、小肠、结肠、大脑和视网膜。我们最近发现,一些非甾体抗炎药(NSAIDs)抑制 SMCT1 的活性。在这里,我们评估了另一种 NSAID 双氯芬酸对 SMCT1 的影响。SMCT1 cDNA 在人视网膜色素上皮细胞系 HRPE 和 ARPE-19、人乳腺上皮细胞系 MCF7 以及非洲爪蟾卵母细胞中异源表达。通过底物摄取和底物诱导电流来监测转运。Na(+)-依赖性摄取/电流被认为是 SMCT1 活性。评估了双氯芬酸的特异性、剂量反应和对转运动力学的影响。为了研究双氯芬酸作用的特异性,我们在相同条件下评估了这种 NSAID 对几种其他克隆转运体在哺乳动物细胞中的活性的影响。与几种抑制 SMCT1 的 NSAIDs 相反,双氯芬酸在 HRPE 和 ARPE-19 细胞中表达时刺激 SMCT1。这种刺激非常明显,取决于双氯芬酸的浓度,范围为 2-5 倍。刺激伴随着转运系统的最大速度的增加以及底物亲和力的增加。观察到的对 SMCT1 的影响是选择性的,因为当在 HRPE 细胞中表达并在相同条件下研究时,几种其他克隆转运体的活性不受双氯芬酸的影响。有趣的是,在 HRPE 和 ARPE-19 细胞中观察到的对 SMCT1 的刺激作用在 MCF7 细胞或 X. laevis 表达系统中并不明显,这表明 SMCT1 不是双氯芬酸的直接靶标。RPE 特异性效应表明,介导刺激作用的双氯芬酸的靶标在 RPE 细胞中表达,但不在 MCF7 细胞或 X. laevis 卵母细胞中表达。由于 SMCT1 是对代谢重要化合物(如丙酮酸、乳酸、β-羟丁酸和烟碱酸)具有浓缩作用的转运体,因此双氯芬酸在 RPE 细胞中对其活性的刺激具有生物学和临床意义。